Skip to content

Structured Online Contraceptive Counseling (LOWE Trial) at Emergency Contraception (EC) Pharmacy Provision LOWE+EC=LOWEC

Structured Online Contraceptive Counseling at Emergency Contraception Pharmacy Provision - A Cluster Randomized Crossover Trial - (The LOWEC Trial)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06299475
Acronym
LOWEC
Enrollment
600
Registered
2024-03-07
Start date
2024-05-27
Completion date
2026-09-01
Last updated
2026-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

eHealth, Emergency Contraception, Over-the-counter

Brief summary

To increase sexual and reproductive health and rights through the improvement of contraceptive counseling and easy access to service and, thus, women's use of effective contraceptives after purchase of an emergency contraceptive pill (ECP).

Detailed description

This pragmatic cluster randomised cross-over controlled trial aims to determine whether the composite intervention of online contraceptive counseling at the time of a pharmacy provision of emergency contraceptive pill (ECP), plus an invitation to a sexual and reproductive health clinic, will result in increased use of subsequent effective contraception (hormonal or intrauterine) compared with standard care. The study will be conducted at approximately 30 pharmacies in the Stockholm Region. Clients who will buy an ECP (without prescription) at one of these pharmacies will be invited by posters and pharmacy personnel to participate in the study. By scanning a quick response (QR) code they will receive more information about the study. Eligible women who choose to participate in the study and give their consent will be allocated to intervention or control group depending on the visited pharmacy's allocation. Participants at the intervention pharmacies will receive an intervention package with online structured contraceptive counseling followed by an online invitation to a clinic for contraceptive provision. While participants at the control pharmacies will purchase the ECP without any further guidance. The order in which the pharmacies will provide the intervention or control will be randomly assigned at a ratio 1:1 by an independent statistician. The recruitment will halter for an intervening period of at least two weeks when the pharmacies switch to the new group depending on their first allocation (cross-over). An online baseline questionnaire and follow-up questionnaires will be collected at 1 and 12 months following the ECP provision for participants both from intervention and control pharmacies. The randomized controlled trial will be conducted together with a process evaluation.

Interventions

OTHEROnline counseling and invitation

Online counseling - An educational video including contraceptive models, four key questions and an effectiveness chart (the LOWE intervention material). Invitation to a clinic - access by weblinks to a regional or national website

Sponsors

Karolinska Institutet
Lead SponsorOTHER
the Swedish Pharmacy Association
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

A cluster randomized crossover trial

Eligibility

Sex/Gender
FEMALE
Age
15 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women \>/=15 years visiting a pharmacy to buy ECP for her own use * Has a smartphone with an electronic identification and ability to scan a QR code * Ability to read Swedish or English * Willing and able to provide informed consent * Willing to participate in the follow-up

Exclusion criteria

\* Ongoing pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Use of effective contraceptionat 1 month follow-up from the pharmacy visitParticipant´s self-reported use in a digital questionnaire of regular effective contraception (hormonal or intrauterine)

Secondary

MeasureTime frameDescription
Contraceptive usewithin 12 months follow-upContraceptive use, including long-acting reversible contraception (LARC) (self-reported use in a digital questionnaire)
Incidence of pregnancy and abortionwithin 12 months follow-upPregnancy and abortion (self-reported use in a digital questionnaire or scrutinized medical record, if lost to follow-up)
Satisfaction with the interventionAt 1 month follow-up from the pharmacy visitParticipants' satisfaction with the intervention package (self-reported use in a digital questionnaire) Assessed as: very satisfied, satisfied, neither nor, dissatisfied, very dissatisfied
Contraceptive use, pregnancy, abortion and satisfaction in vulnerable groupswithin 12 months follow-upContraceptive use, pregnancy, abortion and satisfaction in vulnerable groups such as youths and migrants, compared to non-migrants and older participants (self-reported use in a digital questionnaire or scrutinized medical record, if lost to follow-up)
Process evaluationwithin 12 months follow-upHow context affects the implementation and outcomes among participants and pharmacy personnel (individual interviews)

Countries

Sweden

Contacts

PRINCIPAL_INVESTIGATORKarin Emtell Iwarsson, PhD

WHO-centre, Karolinska Institutet, Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026